Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.

Vagus nerve stimulation is a social-media sensation, promising instant stress relief. Here’s what the science really says ...

Many medications can cause memory loss, including benzodiazepines, opioids, certain antidepressants, and antihistamines.

The FDA approved Lynkuet, a new nonhormonal menopause drug that reduces moderate to severe hot flashes and night sweats.

Prescription sleep drugs are impairing the physical and brain health of aging Americans A person's lifetime rate of falls should decline by nearly 9% if seniors stop taking sleep drugs People also ...

A sleep apnea device company that’s been a darling of Minnesota’s medtech scene lost more than 40% of its value in the past five days as investors realized the competitive threat posed by new weight ...

A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The research simulated the effects of cholesterol-lowering drugs and showed up to ...

CHICAGO -- A novel combination drug targeting neuromuscular dysfunction in obstructive sleep apnea (OSA) reduced severity of the condition in two pivotal randomized trials. For those who also ...

Dean J. Miller does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says. Type 2 diabetes patients taking GLP-1 drugs were overall less likely ...

Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says. Type 2 diabetes patients taking GLP-1 drugs were overall less likely ...

All type 2 diabetes patients who took GLP-1 drugs were less likely to die within a year However, those with sleep apnea had an additional 20% lower risk of dying TUESDAY, Oct. 21, 2025 (HealthDay News ...